23 Jun, 2023 02:40 PM
Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), the only ASX-listed clinical stage cell therapy company, announces the successful completion of its Securities P...read more
28 Apr, 2023 06:36 PM
Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), an Australian leader in cell therapy, is pleased to provide a summary of its activities for the quarter end...read more